Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6167176 | Urology | 2015 | 7 Pages |
Abstract
Distance to treatment facility did not impact quality measures including time to cystectomy or use of neoadjuvant chemotherapy, and there was no difference in cancer-specific mortality between distance groups. There was a detrimental association of increased travel distance with 90-day mortality, which could reflect disparities in access to care after cystectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ahmed Q. Haddad, Nirmish Singla, Neil Gupta, Ganesh V. Raj, Arthur I. Sagalowsky, Vitaly Margulis, Yair Lotan,